Deals
Myovant’s deal with Pfizer for $650M up front is the latest sign women’s health is back
Dec 28, 2020 | 11:28 PM GMT
Pfizer’s partnership with Myovant sends another signal that plenty of opportunity still exists in women’s health, despite recent pharma exits.
In teaming up with Pfizer Inc.